Over 4.7m people in SA placed on new HIV med in four years

In what is likely one of the largest treatment rollouts in South African history, well over four million people living with HIV have started taking the antiretroviral dolutegravir since its introduction around four years ago. Now, according to a recent study published in the Lancet medical journal, use of dolutegravir in South Africa is associated with more people staying on treatment and higher rates of viral suppression. Elri Voigt unpacks the study findings and assesses progress in the country’s switch to dolutegravir-based HIV treatment.

Read More

How death is handled in health facilities – Can we do better?

There is nothing humans can do about the fact that everyone dies eventually, but there may be room to do better when it comes to how some doctors, nurses, and care workers break the news of dying and death; and also how they give practical support to a grieving family. Ufrieda Ho looks at what measures are in place to guide healthcare workers, patients, and their families through this process in health facilities.

Read More

COVID-19: Local researchers welcome Sputnik V vaccine findings

Local researchers have welcomed impressive phase III findings for the Russian-made Sputnik V vaccine published this week in the Lancet medical journal. It is the sixth COVID-19 vaccine found to be effective in preliminary data from a phase III randomised controlled trial and the fourth to have phase III findings published in a leading medical journal.

Read More